Why the study?
Do antithrombotic strategies (adding a P2Y12 inhibitor to aspirin) prevent graft failure in patients after coronary artery bypass graft?
Do antithrombotic strategies (adding a P2Y12 inhibitor to aspirin) prevent graft failure in patients after coronary artery bypass graft?
This review aims to guide clinical decision-making regarding the selection of antithrombotic strategies after CABG.
inhibitor (such as clopidogrel, ticagrelor, or prasugrel) to aspirin, yielding mixed results. This article aims to inform clinical decision-making and guide the selection of antithrombotic strategies after CABG.
No takes yet. Share an insight, caveat, or question.
Mauro et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: